(The Translational Genomics Research Institute) A new skin cancer drug tested for the first time in the world five years ago at the Virginia G.
Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the US Food and Drug Administration, a remarkable accomplishment in new drug development.